Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine



Rating:

Share or cite this content

Citations should be made in the following way:
Patrick Pauwels (Belgium). Molecular diagnosis for oncogenic addictions. New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Member's Comments

No comment yet.

Related content which might interest you: Molecular characterization and diagnosis of ALK+NSCLC Source: International Congress 2015 – Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient Year: 2015 Molecular pathology Source: Eur Respir Monogr 2015; 68: 95-118 Year: 2015 Immunohistochemistry versus DNA testing for detection of EGFR mutations and ALK rearrangements in lung adenocarcinoma patients Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 What are the main mechanisms of oncogenic addiction? Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Molecular pathway perturbations in pulmonary sarcoidosis Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Molecular diagnosis of the inherited disorders of surfactant homeostasis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 New outlook on the Th1/Th2-alternative signaling pathways in asthma Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Molecular and genetic mechanisms in gender issues Source: Virtual Congress 2021 – Highlights on gender and respiratory health Year: 2021 Molecular predictors of disease progression: have we made any progress? Source: International Congress 2016 – Molecular footprints in lung cancer diagnosis and management Year: 2016